DE69217357D1 - Pharmaceutical compositions for use as mast cell stabilizers - Google Patents

Pharmaceutical compositions for use as mast cell stabilizers

Info

Publication number
DE69217357D1
DE69217357D1 DE69217357T DE69217357T DE69217357D1 DE 69217357 D1 DE69217357 D1 DE 69217357D1 DE 69217357 T DE69217357 T DE 69217357T DE 69217357 T DE69217357 T DE 69217357T DE 69217357 D1 DE69217357 D1 DE 69217357D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
mast cell
cell stabilizers
ingredient
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69217357T
Other languages
German (de)
Other versions
DE69217357T2 (en
Inventor
Ann Louise Bazin
Patricia Elaine Koochaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69217357D1 publication Critical patent/DE69217357D1/en
Application granted granted Critical
Publication of DE69217357T2 publication Critical patent/DE69217357T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Pharmaceutical compositions for the stabilization of mast cells or antihistamine activity comprising a bicyclic aromatic flavour compound as active ingredient or in combination with an auxiliary mast cell stabilizing ingredient.
DE69217357T 1992-05-26 1992-05-26 Pharmaceutical compositions for use as mast cell stabilizers Expired - Fee Related DE69217357T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92304711A EP0571670B1 (en) 1992-05-26 1992-05-26 Pharmaceutical compositions for use as mast cell stabilizer

Publications (2)

Publication Number Publication Date
DE69217357D1 true DE69217357D1 (en) 1997-03-20
DE69217357T2 DE69217357T2 (en) 1997-07-10

Family

ID=8211373

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69217357T Expired - Fee Related DE69217357T2 (en) 1992-05-26 1992-05-26 Pharmaceutical compositions for use as mast cell stabilizers

Country Status (6)

Country Link
EP (2) EP0571670B1 (en)
AT (1) ATE148627T1 (en)
DE (1) DE69217357T2 (en)
DK (1) DK0571670T3 (en)
ES (1) ES2097282T3 (en)
GR (1) GR3022503T3 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
EP0917873B1 (en) * 1996-09-26 2006-08-16 Rohto Pharmaceutical Co., Ltd. Eyedrops
WO2000016771A1 (en) * 1998-09-24 2000-03-30 Fujisawa Pharmaceutical Co., Ltd. Liquid preparations for external use containing sodium cromoglicate and method for treating or preventing eye allergic symptoms
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
CN104634628B (en) * 2014-12-16 2017-03-29 广东腾飞基因科技有限公司 A kind of blood stabilizer and its application
US20220265670A1 (en) * 2019-05-22 2022-08-25 Ac Bioscience Sa Composition and use thereof for the treatment of cutaneous mastocytosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715975A (en) * 1967-11-24 1969-05-28

Also Published As

Publication number Publication date
DK0571670T3 (en) 1997-08-18
EP0571670A1 (en) 1993-12-01
EP0571670B1 (en) 1997-02-05
EP0670161A1 (en) 1995-09-06
ATE148627T1 (en) 1997-02-15
ES2097282T3 (en) 1997-04-01
GR3022503T3 (en) 1997-05-31
DE69217357T2 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
ATE225168T1 (en) USE OF LYCOPEN TO REDUCE CELL ACTIVITY, PARTICULARLY OF CANCER CELLS, AND CORRESPONDING PHARMACEUTICAL PREPARATIONS
ES2045229T3 (en) 1,3-DISUBSTITUTED PYRROLIDINS.
PT976760E (en) OLIGOPEPTIDOS WITH FUNGICIDAL ACTIVITY
KR950700282A (en) S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient
MX9206577A (en) PHARMACEUTICAL COMPOSITION TO INHIBIT THE GROWTH OF TUMOR CELLS
UA26303A1 (en) PHARMACEUTICAL COMPOSITION WITH IMHUSOSPRESSOR AND ACTIMICROBIAL ACTIVITY
SV1994000071A (en) PROCEDURE OF A STAGE FOR THE MANUFACTURE OF 3-CHINOLONCARBOXYLIC ACID DERIVATIVES, REF. LE A 29 572-SV.
IE873125L (en) Benzimidazole derivatives
DE59407457D1 (en) BLOCKING THE ADMINISTRATION OF GermS IN HUMAN CELLS
IL79084A0 (en) E-isomers of n alpha-(2-cyano-2-alkoximinoacetyl)-amino acid derivatives and peptides,their preparation and their use as pesticides
ATE148627T1 (en) PHARMACEUTICAL COMPOSITIONS FOR USE AS MAST CELL STABILIZERS
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
DE69318710D1 (en) Antitussivum
IE870845L (en) N'-substituted-n,n'-diacylhydrazines
NO301826B1 (en) Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives, drugs containing them and their use in the manufacture of drugs
ES2057053T3 (en) BENZOHETEROCICLICOS COMPOUNDS.
ES2135535T3 (en) TIAZOLOTRIAZOL AND TIAZOLODIAZOL DERIVATIVES WITH FUNGICIDE ACTIVITY.
AU2956292A (en) Heterocyclic compound and cardiotonic containing the same as active ingredient
DK0699030T3 (en) Microbicidal agents
CO4370014A1 (en) STABLE DIRECTROMYCIN INJECTABLE SOLUTIONS
AU623386B2 (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4- triazoles
WO1995016452A3 (en) Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
EP0264017A3 (en) Pharmaceutical compositions having healing activity
ES2086449T3 (en) 2-TERBUTIL-4-CHLORINE-5- (4-IBUTILMETILCICLOHEXIL) -METILTIO-3 (H) -PIRIDAZINONE WITH ACARICIDE AND INSECTICIDE ACTIVITY.
MX9704491A (en) Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee